The review covers the pharmacochemical study of two receptor types, the neuronal nicotinate receptor and the glutamate receptor. The structure(activity relationship of dicationic blockers on the neuronal ion channel of the nicotinic acetylcholine receptor (nAChR) was studied to estimate the pore size in the cross section of the channel. A topographic model of the blocker binding site was proposed. It included two constrictions, a large one and a small one. The small constriction was located between the large one and the cytoplasmic end of the pore. The cross-sectional dimensions of the large and small constrictions that were estimated from the dimensions of the blockers were 6.1 × 8.3 Å and 5.5 × 6.4 Å, respectively; the spacing between the constrictions along the pore, ~7 Å. Acomparison of the topographic model with a molecular five-helix bundle model of the nAChR pore predicted that serine and threonine rings were the most probable candidates for the large and small constrictions, respectively. Replacement of aliphatic radicals on nitrogen atoms in dications by cyclic radicals led to the creation of a new class of compounds capable of blocking open ion channels of GluA1 α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (Ca2+-permeable). It was found that N-methyl-D-aspartate (NMDA) receptor channels were blocked by both mono- and dicationic compounds while AMPA channels could be effectively blocked only by dicationic compounds of a certain length. The prospects for the use of combined (NMDA + AMPA) blockers as neuroprotective, anticancer, and antiviral agents were discussed.
Similar content being viewed by others
References
N. B. Brovtsyna, D. B. Tikhonov, O. B. Gorbunova, et al., J. Membr. Biol., 152, 77 – 87 (1996).
N. Y. Lukomskaya and V. E. Gmiro, J. Auton. Nerv. Syst., 6, 363 – 371 (1982).
D. B. Tikhonov, N. N. Potap’eva, V. E. Gmiro, et al., Biol. Membr., 13, 185 – 195 (1996).
B. S. Zhorov, N. B. Brovtsyna, V. E. Gmiro, et al., J. Membr. Biol., 121, 119 – 132 (1991).
S. M. Antonov, J. W. Johnson, N. Y. Lukomskaya, et al., Mol. Pharmacol., 47, 558 – 567 (1995).
K. V. Bolshakov, D. B. Tikhonov, V. E. Gmiro, and L. G. Magazanik, Neurosci. Lett., 291, No. 2, 101 – 104 (2000).
L. G. Magazanik, S. M. Antonov, N. Ya. Lukomskaya, et al., Fiziol. Zh. im. I. M. Sechenova, 80, 99 – 112 (1994).
L. G. Magazanik, K. V. Bol’shakov, S. L. Buldakova, et al., Ross. Fiziol. Zh. im. I. M. Sechenova, 86, 1138 – 1151 (2000).
M. V. Samoilova, E. V. Frolova, N. N. Potapjeva, et al., Invertebr. Neurosci., 3, 117 – 126 (1997).
W. D. Paton and E. J. Zaimis, Br. J. Pharmacol. Chemother., 4(4), 381 – 400 (1949).
N. V. Khromov-Borisov, V. E. Gmiro, and N. Ya. Lukomskaya, SU Pat. No. 757,520, Aug. 23, 1980; Byull. Izobret., 1980, No. 31.
N. Ya. Lukomskaya and V. E. Gmiro, Dokl. Akad. Nauk SSSR, 265(3), 743 – 747 (1982).
V. I. Skok, A. A. Selyanko, V. A. Derkach, et al., Neurophysiology, 16(1), 46 – 52 (1984).
S. Kertser, A. Bobryshev, S. Voitenko, et al., J. Membr. Biol., 163(2), 111 – 118 (1998).
V. E. Gmiro, N. B. Brovtsyna, S. E. Serdyuk, and N. Ya. Lukomskaya, Bioorg. Khim., 28(2), 135 – 146 (2002).
B. S. Zhorov, N. B. Brovtsyna, V. E. Gmiro, et al., Biol. Membr., 6(10), 1069 – 1084 (1989).
N. B. Brovtsyna, V. E. Gmiro, O. B. Gorbunova, et al., Biol. Membr., 13(1), 57 – 70 (1996).
D. E. Kurennyi, V. A. Derkach, V. E. Gmiro, and V. I. Skok, Neirofiziologiya, 20, 826 – 829 (1988).
V. E. Gmiro, N. B. Brovtsyna, O. B. Gorbunova, et al., Dokl. Ross. Akad. Nauk, 341, 699 – 705 (1995).
V. E. Gmiro, S. D. Groisman, N. Ya. Kukomskaya, et al., Dokl. Akad. Nauk SSSR, 292(2), 497 – 501 (1987).
I. N. Remizov, V. Yu. Maslov, E. E. Purnyn?, et al., Neirofiziologiya, 27(5/6), 323 – 330 (1995).
D. E. Kurenny, A. A. Selyanko, V. A. Derkach, et al., J. Auton. Nerv. Syst., 48, 231 – 240 (1994).
V. I. Skok, S. D. Groisman, L. V. Melnitchenko, et al., J. Auton. Nerv. Syst., 35, 211 – 217 (1991).
V. E. Gmiro, L. N. Gavrovskaya, E. N. Kharchevnikova, et al., RU Pat. No. 2,014,074, Jun. 15, 1994; Byull., No. 11.
V. E. Gmiro, P. D. Shabanov, and S. E. Serdyuk, RU Pat. No. 2,597,616, Sept. 10, 2016; Byull., No. 25.
L. V. Mel?nichenko, V. V. Gerzanich, V. E. Gmiro, and V. I. Skok, Fiziol. Zh. SSSR im. I. M. Sechenova, 75(3), 318 – 326 (1989).
L. G. Magazanik, S. M. Antonov, and V. E. Gmiro, Biol. Membr., 1(2), 130 – 140 (1984).
L. G. Magazanik, S. L. Buldakova, M. V. Samoilova, et al., J. Physiol., 505(3), 655 – 663 (1997).
S. E. Serdyuk and V. E. Gmiro, Byull. Eksp. Biol. Med., 143(5), 548 – 550 (2007).
V. E. Gmiro, S. E. Serdyuk, and O. M. Efremov, Byull. Eksp. Biol. Med., 146(7), 22 – 25 (2008).
L. G. Magazanik, S. M. Antonov, N. Ya. Lukomskaya, et al., Fiziol. Zh. im. I. M. Sechenov, 80(7), 99 – 111 (1994).
V. E. Gmiro and S. E. Serdyuk, Khim.-farm. Zh., 53(3), 21 – 25 (2019); Pharm. Chem. J., 53(3), 212 – 215 (2019).
V. I. Skok, S. D. Groisman, L. V. Melnitchenko, et al., J. Auton. Nerv. Syst., 35(3), 211 – 217 (1991).
V. N. Serebryakov, R. Shubert, V. E. Gmiro, and P. D. Brezhestovskii, Biol. Membr., 8(9), 959 – 965 (1991).
V. V. Shipachev, A. A. Timoshin, V. E. Gmiro, et al., Biol. Membr., 14(3), 262 – 269 (1997).
V. E. Gmiro and S. E. Serdyuk, Ross. Zh. Fiziol. Im. I. M. Sechenova, 103(10), 1106 – 1113 (2017).
I. N. Abdurasulova, A. V. Matsulevich, S. E. Serdyuk, and V. E. Gmiro, J. Mult. Scler. (Foster City), 5(1), 217 (2018).
S. A. Upton, Nat. Rev. Drug Discovery, 5, No. 2, 160 – 170 (2006).
R. Dingledine, K. Barges, D. Bowie, and S. F. Traynelis, Pharmacol. Rev., 51, 8 – 61 (1999).
N. Burnashev, Z. Zhou, E. Neher, and B. Sakmann, J. Physiol. (London, U. K.). 485, 403 – 418 (1995).
G. T. Swanson, S. K. Kamboj, and S. J. Cull-Candy, J. Neurosci., 17, 58 – 69 (1997).
L. G. Magazanik, M. V. Samoilova, S. L. Buldakova, et al., Ross. Fiziol. Zh. im. I. M. Sechenova, 83, 19 – 29 (1997).
D. B. Tikhonov, M. V. Samoilova, S. L. Buldakova, et al., Br. J. Pharmacol., 129, 265 – 274 (2000).
E. A. Cavalheiro and J. W. Olney, Proc. Natl. Acad. Sci. USA, 98, 5947 – 5948 (2001).
H. S. Chen and S. A. Lipton, J. Neurochem., 97, 1611 – 1626 (2006).
A. Yoshioka, N. Ikegaki, M. Williams, and D. Pleasure, J. Neurosci. Res., 46, 164 – 172 (1996).
E. Aronica, B. Yankaya, and G. H. Jansen, Neuropathol. Appl. Neurobiol., 27, 223 – 237 (2001).
S. Ishiuchi, K. Tsuzuki, Y. Yoshida, et al., Nat. Med., 8, 971 – 978 (2002).
S. A. Lyons,W. J. Chung, A. K. Weaver, et al., Cancer Res., 67, 9463 – 9471 (2007).
S. Ishiuchi, Y. Yoshida, K. Sugawara, et al., J. Neurosci., 27, 7987 – 8001 (2007).
H. Hu, N. Takano, L. Xiang, et al., Oncotarget, 5, 8853 – 8868 (2014).
W. Rzeski, L. Turski, and C. Ikonomidou, Proc. Natl. Acad. Sci. USA, 98(11), 6372 – 6377 (2001).
A. Stepulak, M. Sifringer, W. Rzeski, et al., Proc. Natl. Acad. Sci. USA, 102, 15605 – 15610 (2005).
A. Stepulak, H. Luksch, and O. Uckermann, Anticancer Res., 31, 565 – 573 (2011).
W. G. North, G. Gao, V. A. Memoli, et al., Breast Cancer Res. Treat., 122, 307 – 314 (2010).
F. Yamaguchi, Y. Hirata, H. Akram, et al., BMC Cancer, 13, 468 (2013).
M. Abdul and N. J. Hoosein, J. Membr. Biol., 205, 125 – 128 (2005).
Z. Song, C. D. He, J. Liu, et al., Exp. Dermatol., 21, 926 – 931 (2012).
W. G. North, G. Gao, A. Jensen, et al., Clin. Pharmacol., 2, 31 – 40 (2010).
V. Venkataramani, D. I. Tanev, C. Strahle, et al., Nature, 573(7775), 532 – 538 (2019).
M. Roslin, R. Henriksson, P. Bergstrom, et al., J. Neurooncol., 61(2), 151 – 160 (2003).
T. Hanada, Y. Hashizume, N. Tokuhara, et al., Epilepsia, 52(7), 1331 – 1340 (2011).
V. E. Gmiro, S. E. Serdyuk, and O. S. Veselkina, Byull. Eksp. Biol. Med., 160(7), 80 – 83 (2015).
V. E. Gmiro, S. E. Serdyuk, and O. S. Veselkina, Khim.-farm. Zh., 52(10), 13 – 17 (2018); Pharm. Chem. J., 52(10), 830 – 834 (2019).
V. E. Gmiro, S. E. Serdyuk, and O. S. Veselkina, Ross. Fiziol. Zh. im. I. M. Sechenova, 103(6), 645 – 657 (2017).
B. S. Meldrum and M. A. Rogawski, Neurotherapeutics, 4(1), 18 – 61 (2007).
V. E. Gmiro, S. E. Serdyuk, and O. S. Veselkina, Khim.-farm. Zh., 53(1), 30 – 35 (2019); Pharm. Chem. J., 53(1), 29 – 34 (2019).
S. E. Serdyuk and V. E. Gmiro, Ross. Fiziol. Zh. im. I. M. Sechenova, 99(12), 1361 – 1365 (2013).
O. Kopach, V. Krotov, J. Goncharenko, and N. Voitenko, Front. Cell. Neurosci., 10, 50 (2016).
S. E. Serdyuk, V. E. Gmiro, and O. S. Veselkina, Byull. Eksp. Biol. Med., 157(1), 19 – 22 (2014).
V. E. Gmiro, S. E. Serdyuk, and O. S. Veselkina, Ross. Fiziol. Zh. im. I. M. Sechenova, 103(3), 299 – 306 (2017).
I. N. Abdurasulova, S. E. Serdyuk, and V. E. Gmiro, Neiroimmunologiya, 5(1), 4 – 11 (2007).
J. L. Nargi-Aizenman, M. B. Havert, M. Zhang, et al., Ann. Neurol., 55(4), 541 – 549 (2004).
O. Bar-Peled, R. O’Brien, J. Morrison, et al., NeuroReport, 10, 855 – 859 (1999).
T. Williams, N. Day, P. Ince, et al., Ann. Neurol., 42, 200 – 207 (1997).
V. Siddharthan, H. Wang, A. L. de Oliveira, et al., Antiviral Chem. Chemother., 28, 2040206620950143 (2020).
S. Hasanagic and F. Serdarevic, Eur. Respir. J., 56(2), 2001610 (2020).
A. Cortes-Borra and G. E. Aranda-Abreu, Pharmacol. Reports., 73, 962 – 965 (2021).
D. B. Tikhonov and L. G. Magazanik, Ross. Fiziol. Zh. im. I. M. Sechenova, 96(7), 726 – 739 (2010).
K. V. Bolshakov, K. H. Kim, N. N. Potapjeva, et al., Neuropharmacology, 49(2), 144 – 155 (2005).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 6, pp. 3 – 17, June, 2023.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gmiro, V.E. Dication Molecules as Tools for Studying Actylcholine and Glutamate Receptors (Review). Pharm Chem J 57, 763–776 (2023). https://doi.org/10.1007/s11094-023-02951-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-023-02951-9